John Campbell

John Campbell currently serves as the VP Head of Chemistry at Allorion Therapeutics, a position held since February 2024. Prior to this role, John held the position of VP of Chemistry at Reverie Labs from October 2021 to February 2024 and served as Director of Medicinal Chemistry at Blueprint Medicines between October 2018 and October 2021. John's career also includes experience as a Medicinal Chemist at Epizyme and Sunovion Pharmaceuticals Inc. from November 2012 to October 2018 and March 2006 to November 2012, respectively. Early in John's career, a role as a Postdoctoral Associate at Boston College was undertaken from January 2004 to March 2006 under the supervision of Amir H. Hoveyda. Education includes a Postdoctoral degree in Chemistry from Boston College and a Ph.D. in Organic Chemistry from the University of Wisconsin-Madison.